» Articles » PMID: 29786640

Vitamin D in Vascular Calcification: A Double-Edged Sword?

Overview
Journal Nutrients
Date 2018 May 23
PMID 29786640
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Vascular calcification (VC) as a manifestation of perturbed mineral balance, is associated with aging, diabetes and kidney dysfunction, as well as poorer patient outcomes. Due to the current limited understanding of the pathophysiology of vascular calcification, the development of effective preventative and therapeutic strategies remains a significant clinical challenge. Recent evidence suggests that traditional risk factors for cardiovascular disease, such as left ventricular hypertrophy and dyslipidaemia, fail to account for clinical observations of vascular calcification. Therefore, more complex underlying processes involving physiochemical changes to mineral balance, vascular remodelling and perturbed hormonal responses such as parathyroid hormone (PTH) and fibroblast growth factor 23 (FGF-23) are likely to contribute to VC. In particular, VC resulting from modifications to calcium, phosphate and vitamin D homeostasis has been recently elucidated. Notably, deregulation of vitamin D metabolism, dietary calcium intake and renal mineral handling are associated with imbalances in systemic calcium and phosphate levels and endothelial cell dysfunction, which can modulate both bone and soft tissue calcification. This review addresses the current understanding of VC pathophysiology, with a focus on the pathogenic role of vitamin D that has provided new insights into the mechanisms of VC.

Citing Articles

Risk factors for radial artery calcification in patients with and without uremia.

Hao J, Wang S, Chen T, Yuan B, Hao L BMC Nephrol. 2025; 26(1):18.

PMID: 39799338 PMC: 11724451. DOI: 10.1186/s12882-024-03940-0.


Vitamin D, C-Reactive Protein, and Increased Fall Risk: A Genetic Epidemiological Study.

Sutherland J, Zhou A, Hypponen E Nutrients. 2025; 17(1.

PMID: 39796472 PMC: 11722653. DOI: 10.3390/nu17010038.


Monitoring of microvascular calcification by time-resolved photoacoustic microscopy.

Ma H, Yu Y, Zhu Y, Wu H, Qiu H, Gu Y Photoacoustics. 2024; 41:100664.

PMID: 39654983 PMC: 11626619. DOI: 10.1016/j.pacs.2024.100664.


Tetrandrine ameliorated atherosclerosis in vitamin D3/high cholesterol diet-challenged rats via modulation of miR-34a and Wnt5a/Ror2/ABCA1/NF-kB trajectory.

El Zouka Y, Sheta E, Abdelrazek Salama M, Selima E, Refaat R, Salaheldin Abdelhamid Ibrahim S Sci Rep. 2024; 14(1):21371.

PMID: 39266573 PMC: 11393063. DOI: 10.1038/s41598-024-70872-y.


Inflammation-associated ectopic mineralization.

Song J, Liu M, Ma Y, Wan Q, Li J, Diao X Fundam Res. 2024; 3(6):1025-1038.

PMID: 38933004 PMC: 11197766. DOI: 10.1016/j.fmre.2022.04.020.


References
1.
Hruska K, Mathew S, Saab G . Bone morphogenetic proteins in vascular calcification. Circ Res. 2005; 97(2):105-14. DOI: 10.1161/01.RES.00000175571.53833.6c. View

2.
Chen J, Budoff M, Reilly M, Yang W, Rosas S, Rahman M . Coronary Artery Calcification and Risk of Cardiovascular Disease and Death Among Patients With Chronic Kidney Disease. JAMA Cardiol. 2017; 2(6):635-643. PMC: 5798875. DOI: 10.1001/jamacardio.2017.0363. View

3.
Holick M, MacLAUGHLIN J, Doppelt S . Regulation of cutaneous previtamin D3 photosynthesis in man: skin pigment is not an essential regulator. Science. 1981; 211(4482):590-3. DOI: 10.1126/science.6256855. View

4.
Sigrist M, Taal M, Bungay P, McIntyre C . Progressive vascular calcification over 2 years is associated with arterial stiffening and increased mortality in patients with stages 4 and 5 chronic kidney disease. Clin J Am Soc Nephrol. 2007; 2(6):1241-8. DOI: 10.2215/CJN.02190507. View

5.
Yang H, Curinga G, Giachelli C . Elevated extracellular calcium levels induce smooth muscle cell matrix mineralization in vitro. Kidney Int. 2004; 66(6):2293-9. DOI: 10.1111/j.1523-1755.2004.66015.x. View